FP03 Niacinamide decreases the inflammatory response of macrophages and enhances the survival of ultraviolet radiation-exposed macrophages

Clicks: 6
ID: 318363
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #76 of 313 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 313 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction and aims Skin-resident macrophages are strongly influenced by ultraviolet (UV) radiation (UVR). Hence, this study investigates how niacinamide, a vitamin B3 derivative with anti-inflammatory properties widely used in skincare, influences their differentiation, polarization and inflammatory responses [reactive oxygen species (ROS) production, caspase-1 activity, and cytokine release] with or without UVR exposure. Methods THP-1-derived macrophages were used as a model for skin-resident macrophages to study the effects of direct UVR and indirect exposure via UV-irradiated keratinocyte supernatant. Niacinamide was tested on M0, M1 and M2 macrophages with or without UVR or supernatant treatment at 24 and/or 48 h for its impact on cell viability (Annexin V, 7AAD, LiveDead), macrophage differentiation/polarization [CD11b(M0), CD169(activation), CD80(M1), HLA-DR(M1), CD200R(M2)] and cytokine release [interleukin (IL)-8, IL-6, IL-1β, tumour necrosis factor (TNF)-α, IL-10] by flow cytometry. ROS and caspase-1 activity were measured in M0, M1, and M2 macrophages using commercial fluorescence- and luminescence-based assays, respectively. Results Niacinamide significantly mitigated UVR-induced apoptosis and necrosis in M0 THP-1 cells (P ≤ 0.001). In M1 macrophages, it lowered CD80 expression [geometric mean fluorescence intensity (GMFi)] by 30–40%. Although M0 macrophages showed a significant increase in CD200R (P ≤ 0.001), M2 macrophages showed no change. Supernatants from UV-exposed keratinocytes did not affect surface markers in M0, M1 and M2 macrophages, although niacinamide treatment approximately halved CD80 expression (GMFi) in M1 macrophages exposed to these supernatants. Furthermore, niacinamide significantly decreased ROS in lipopolysaccharide (LPS)-treated M0, M1 and M2 macrophages (P ≤ 0.001) and significantly reduced caspase-1 activity in LPS + nigericin-treated M0, M1 and M2 macrophages (P ≤ 0.01). Conclusions Niacinamide improves macrophage viability and influences their polarization towards resolving subtype by enhancing M2 marker expression and by reducing proinflammatory M1 markers, such as CD80. Additionally, niacinamide reduces macrophage inflammatory responses by lowering ROS levels and caspase-1 activity, suggesting its potential to mitigate macrophage-driven inflammation and promote resilience to environmental stressors.
Reference Key
openalex_W7165691624 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Danielle Tan, Rajia Bahri, Sébastien Viatte, Victoria Newton, Silvia Bulfone-Paus
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag151.026
URL
https://doi.org/10.1093/bjd/ljag151.026
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.